148 related articles for article (PubMed ID: 20632465)
1. Human breast cancer stem cells and sex hormones--a narrative review.
Eden JA
Menopause; 2010 Jul; 17(4):801-10. PubMed ID: 20632465
[TBL] [Abstract][Full Text] [Related]
2. Why does oestrogen-only hormone therapy have such a small impact on breast cancer risk? A hypothesis.
Eden JA
Gynecol Endocrinol; 2011 Mar; 27(3):170-5. PubMed ID: 20500114
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer, stem cells and sex hormones. Part 3: the impact of the menopause and hormone replacement.
Eden JA
Maturitas; 2011 Feb; 68(2):129-36. PubMed ID: 21145188
[TBL] [Abstract][Full Text] [Related]
4. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
5. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
6. The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures.
Zhou L; Jiang Y; Yan T; Di G; Shen Z; Shao Z; Lu J
Breast Cancer Res Treat; 2010 Aug; 122(3):795-801. PubMed ID: 20571867
[TBL] [Abstract][Full Text] [Related]
7. Hormones and progeny of breast tumor cells.
Schneider HP; Böcker W
Climacteric; 2006 Apr; 9(2):88-107. PubMed ID: 16698656
[TBL] [Abstract][Full Text] [Related]
8. Insights into the cell of origin in breast cancer and breast cancer stem cells.
Lindeman GJ; Visvader JE
Asia Pac J Clin Oncol; 2010 Jun; 6(2):89-97. PubMed ID: 20565420
[TBL] [Abstract][Full Text] [Related]
9. Potential benefits of estrogens and progestogens on breast cancer.
Schneider HP; Jackisch C
Int J Fertil Womens Med; 1998; 43(6):278-85. PubMed ID: 9920536
[TBL] [Abstract][Full Text] [Related]
10. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
[TBL] [Abstract][Full Text] [Related]
11. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ
Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041
[TBL] [Abstract][Full Text] [Related]
14. The pill and the breast.
Drife JO
IPPF Med Bull; 1984 Dec; 18(6):1-2. PubMed ID: 12313402
[TBL] [Abstract][Full Text] [Related]
15. Links between hormone replacement therapy and neoplasia.
Hulka BS
Fertil Steril; 1994 Dec; 62(6 Suppl 2):168S-175S. PubMed ID: 7958013
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer stem cells.
Kai K; Arima Y; Kamiya T; Saya H
Breast Cancer; 2010 Apr; 17(2):80-5. PubMed ID: 19806428
[TBL] [Abstract][Full Text] [Related]
17. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Hyder SM; Murthy L; Stancel GM
Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
19. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
Reiner GC; Katzenellenbogen BS
Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
[TBL] [Abstract][Full Text] [Related]
20. Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue.
Gadducci A; Biglia N; Cosio S; Sismondi P; Genazzani AR
Gynecol Endocrinol; 2009 Dec; 25(12):807-15. PubMed ID: 19906000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]